Closing remarks - The future of SGLT2 Inhibitor Cardiovascular Outcomes trials: what are we hoping to learn?
28 August 2018 (10:43 - 10:45)
Organised by:
About the speakers
University of Toronto, Toronto (Canada)
Klinikum Ludwigshafen, Ludwigshafen (Germany)
3 More presentations in this session
Professor L. Leiter (Toronto, CA)
Doctor A. Gitt (Ludwigshafen, DE)
Professor L. Leiter (Toronto, CA)
Doctor A. Gitt (Ludwigshafen, DE)
Access the full session
The Event
ESC Congress 2018
28 August 2018
10:43 CET
You may be interested in
Congress Presentation
23 May 2022
Congress Session
Congress Session
